Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Bull Soc Pathol Exot ; 98(4): 302-3, 2005 Nov.
Artigo em Francês | MEDLINE | ID: mdl-16402581

RESUMO

Two snake antivenoms are distributed in Cameroon, though their availability in district hospitals varies. These snake antivenoms are FAV-Afrique (Aventis Pasteur) available at Centre Pasteur Cameroun and Polyvalent serum (Serum Institute of India = SII) distributed by a wholesaler (CENAME). The price remains a very important factor. We have noted that some district hospitals do not stock antivenom at all, while others stock very few and sometimes only one vial whereas a good management of snakebite may require up to 14 vials for some envenomations. However, data collected by the CAMHERP project that permit to identify high-risk areas of envenomation might be used as a database for the distribution of snake antivenom in Cameroon.


Assuntos
Antivenenos , Avaliação das Necessidades/estatística & dados numéricos , Venenos de Serpentes/antagonistas & inibidores , Camarões , Humanos
3.
Mem Inst Oswaldo Cruz ; 87 Suppl 3: 271-3, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1343701

RESUMO

Based on the results of in vitro sensitivity of Plasmodium falciparum to chloroquine, quinine and mefloquine, and evaluation of drug consumption conducted in 1987-1988 in four areas in the north and south-west of Cameroon, two opposite situations were encountered in this country. In northern Cameroon where mefloquine resistance is prevalent a close correlation was found between the responses of P. falciparum to mefloquine and to quinine, but not between mefloquine and chloroquine. In the south, where chloroquine resistance is highly prevalent, no correlation was found neither between mefloquine and chloroquine nor mefloquine and quinine, but the responses to quinine and chloroquine appear partly correlated. These results lead to formulate the hypothesis of a "southern" type of P. falciparum submitted to a high chloroquine drug pressure inducing a secondary cross resistance, whilst a "northern" type submitted to a relatively high and abortive quinine drug pressure inducing a primary quinine resistance and a secondary cross resistance with mefloquine.


Assuntos
Malária Falciparum/tratamento farmacológico , Mefloquina/farmacologia , Plasmodium falciparum/efeitos dos fármacos , Quinina/farmacologia , Animais , Camarões/epidemiologia , Portador Sadio/tratamento farmacológico , Criança , Pré-Escolar , Resistência a Medicamentos , Uso de Medicamentos , Humanos , Lactente , Malária Falciparum/epidemiologia , Mefloquina/uso terapêutico , Quinina/uso terapêutico
4.
Mem. Inst. Oswaldo Cruz ; 87(supl.3): 271-3, 1992.
Artigo em Inglês | LILACS | ID: lil-121114

RESUMO

Based on the results of in vitro sensitivity of Plasmodium falciparum to chloroquine, quinine and mefloquine, and evaluation of drug consumption conducted in 1987-1988 in four areas in the noth and south-west of Cameron, two opposite situations were encountered in this country. In northern Cameron where mefloquine resistance is prevalent a close correlation was found between the responses of P. falciparum to mefloquine and to quinine, but not between mefloquine and chloroquine. In the south, where chloroquine resistance is highly prevalent, no correlation was found neither between mefloquine and chloroquine nor mefloquine and quinine, but the responses to quinine and chloroquine appear partly correlated. These lead to formulate the hypothesis of a "southern" type of P. falciparum submitted to a high chloroquine drug pressure inducing a secondary cross resistance, whilst a "northern"type submitted to a relatively high and abortive quinine drug pressure inducing a primary quinine resistance and a secondary cross resistance with mefloquine


Assuntos
Técnicas In Vitro , Malária/tratamento farmacológico , Plasmodium falciparum , Resistência a Medicamentos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...